600422 昆药集团
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入4,751,206-18.08%8,401,4478,430,1778,282,0638,253,533
减:营业总成本4,530,355-13.09%7,550,2047,663,8507,835,5157,829,085
    其中:营业成本2,878,309-11.67%4,750,1974,500,8264,843,6904,844,777
               财务费用34,306156.09%13,9881,53838,30939,692
               资产减值损失(8,227)-48.39%(21,955)(66,537)(67,592)(19,932)
公允价值变动收益120,658-68,627.25%6,9161,02610,673(960)
投资收益1,431-88.32%14,93317,3125,985150,648
    其中:对联营企业和合营企业的投资收益(187)-33.67%(502)(186)(255)(468)
营业利润379,298-38.87%927,547789,670497,148634,047
利润总额378,421-40.01%934,570786,376477,287631,289
减:所得税费用55,016-56.83%183,350143,70391,827118,075
净利润323,405-35.76%751,221642,674385,459513,214
减:非控股权益54,037-8.13%103,139101,9632,2765,546
股东净利润269,368-39.42%648,081540,711383,184507,668

市场价值指针
每股收益 (元) *0.360-38.98%0.8600.7100.5100.670
每股派息 (元) *----0.3000.2000.1600.270
每股净资产 (元) *7.013-4.03%6.9406.9896.5726.308
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容